Invitation to MorphoSys' First Quarter 2023 Financial Results Conference ... 2023-04-27
Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference ...
Source: pr-inside.com
Page 7 - Thomas Biegi News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Biegi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Biegi Today - Breaking & Trending Today
MorphoSys AG: Invitation to MorphoSys' First Quarter 2023 Financial Results Conference Call on May 4, 2023
Conference Call AlertMUNICH, GERMANY / ACCESSWIRE / April 27, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the first quarter 2023 on May 3, 2023 at 10:00 pm CEST (09:00 pm BST
Source: finanznachrichten.de
Invitation to MorphoSys' First Quarter 2023 Financial Results Conference Call on May 4, 2023
EQS-News: MorphoSys AG / Key word: Quarter Results Invitation to MorphoSys’ First Quarter 2023 Financial Results Conference Call on May 4, 2023 27.04.2023 / 22:03... | June 18, 2023
Source: marketscreener.com
Incyte and MorphoSys U.S. Inc.: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi (tafasitamab-cxix)
Results from the Phase 2 L-MIND study were highlighted as a late-breaking oral presentation at the American Association for Cancer Research Annual Meeting 2023 MorphoSys U.S. Inc., a fully owned subsidiary
Source: finanznachrichten.de
MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023
EQS-News: MorphoSys AG / Key word: Miscellaneous MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023... | April 4, 2023
Source: marketscreener.com